Upregulation of miR-21 has been reported to directly target PTEN promoting thus the growth and metastasis of specific cancers, including non-small cell lung cancer (80), colorectal carcinoma (81), ovarian cancer (82), as well as triple-negative breast cancers (83). This evidence concerns the gene PTEN and ovarian carcinoma.